Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection

Retrovirology

Volumn 7, Issue , 2010, Pages

  van Marle, Guido ^a   Church, Deirdre L ^a,b,c   Nunweiler, Kali D ^a   Cannon, Kris ^a   Wainberg, Mark A ^d,e   Gill, M J ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; VIRUS DNA; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD ANALYSIS; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; DRUG EFFICACY; DUODENUM MUCOSA; ESOPHAGUS MUCOSA; GENE IDENTIFICATION; GENETIC CODE; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; MOLECULAR PHYLOGENY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PHYLOGENETIC TREE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIVERSITY; STOMACH MUCOSA; TISSUE DISTRIBUTION; UNINDEXED SEQUENCE; VIRUS MUTATION; VIRUS RESISTANCE; BLOOD; COLON; DUODENUM; ESOPHAGUS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LYMPH NODE; MALE; MISSENSE MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; STOMACH; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI-HIV AGENTS; BLOOD; COLON; DNA, VIRAL; DRUG RESISTANCE, VIRAL; DUODENUM; ESOPHAGUS; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; LYMPH NODES; MALE; MUTATION, MISSENSE; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STOMACH; VIRAL LOAD; ZIDOVUDINE;

EID: 77956481810     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-74     Document Type: Article

References (67)

1. Richman DD. HIV chemotherapy. Nature 2001, 410:995-1001. 10.1038/35073673, 11309630.
2. Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy 2006, 26:1111-1133. 10.1592/phco.26.8.1111, 16863488.
3. Yeni P. Update on HAART in HIV. J Hepatol 2006, 44:S100-103. 10.1016/j.jhep.2005.11.021, 16359748.
4. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science 1988, 242:1171-1173. 10.1126/science.2460925, 2460925.
5. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science 2001, 292:1106-1109. 10.1126/science.1059128, 11352065.
6. Wodarz D, Nowak MA. The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV. Proc R Soc Lond B Biol Sci 1998, 265:2149-2158.
7. Wolfs TF, de Jong JJ, Van den Berg H, Tijnagel JM, Krone WJ, Goudsmit J. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci USA 1990, 87:9938-9942. 10.1073/pnas.87.24.9938, 55289, 1702224.
8. Rouzine IM, Coffin JM. Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J Virol 1999, 73:8167-8178. 112834, 10482567.
9. Sheehy N, Desselberger U, Whitwell H, Ball JK. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy. J Gen Virol 1996, 77:1071-1081. 10.1099/0022-1317-77-5-1071, 8609473.
10. Brown AJ, Cleland A. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy. Aids 1996, 10:1067-1073.
11. Frost SD, Gunthard HF, Wong JK, Havlir D, Richman DD, Leigh Brown AJ. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy. Virology 2001, 284:250-258. 10.1006/viro.2000.0887, 11384224.
12. Owen A, Khoo SH. Intracellular pharmacokinetics of antiretroviral agents. J HIV Ther 2004, 9:97-101.
13. Pomerantz RJ. Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1. HIV Clin Trials 2003, 4:137-143. 10.1310/80JH-148K-NADQ-U927, 12671782.
14. Lowe SH, Sankatsing SU, Repping S, van der Veen F, Reiss P, Lange JM, Prins JM. Is the male genital tract really a sanctuary site for HIV? Arguments that it is not. Aids 2004, 18:1353-1362. 10.1097/01.aids.0000125979.64033.96, 15199311.
15. Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S. Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection. J Virol 2006, 80:8236-8247. 10.1128/JVI.00120-06, 1563811, 16873279.
16. Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008, 197:714-720. 10.1086/527324, 18260759.
17. Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE. A SIV-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J Virol 2009, 83:9247-54. 10.1128/JVI.00840-09, 2738256, 19570871.
18. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
19. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097. 10.1038/nature03501, 15793563.
20. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003, 77:11708-11717. 10.1128/JVI.77.21.11708-11717.2003, 229357, 14557656.
21. Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, Gurley TC, Allgood S, Haynes BB, Vandergrift NA, Plonk S, Parker DC, Cohen MS, Tomaras GD, Goepfert PA, Shaw GM, Schmitz JE, Eron JJ, Shaheen NJ, Hicks CB, Liao HX, Markowitz M, Kelsoe G, Margolis DM, Haynes BF. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med 2009, 6:e1000107. 10.1371/journal.pmed.1000107, 2702159, 19582166.
22. Estes J, Baker JV, Brenchley JM, Khoruts A, Barthold JL, Bantle A, Reilly CS, Beilman GJ, George ME, Douek DC, Haase AT, Schacker TW. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008, 198:456-464. 10.1086/590112, 2683984, 18598193.
23. van Marle G, Gill MJ, Kolodka D, McManus L, Grant T, Church DL. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology 2007, 4:87. 10.1186/1742-4690-4-87, 2217557, 18053211.
24. al-Mulla W, Church D, Gill MJ. Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV-1 infection. HIV/GI Research Study Group. J Med Virol 1997, 52:31-34. 10.1002/(SICI)1096-9071(199705)52:1<31::AID-JMV6>3.0.CO;2-S, 9131455.
25. Gill MJ, Sutherland LR, Church D, Group T. Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. AIDS 1992, 6:553-556. 10.1097/00002030-199206000-00005, 1388876.
26. Slatkin M, Maddison WP. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989, 123:603-613. 1203833, 2599370.
27. Slatkin M, Maddison WP. Detecting isolation by distance using phylogenies of genes. Genetics 1990, 126:249-260. 1204129, 2227384.
28. Maddison WP, Maddison DR. Mesquite: a modular system for evolutionary analysis. Version 2.71. 2009,
29. Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2003, 31:298-303. 10.1093/nar/gkg100, 165547, 12520007.
30. Haddad DN, Birch C, Middleton T, Dwyer DE, Cunningham AL, Saksena NK. Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells. Aids 2000, 14:2273-2281. 10.1097/00002030-200010200-00008, 11089615.
31. Tirado G, Jove G, Kumar R, Noel RJ, Reyes E, Sepulveda G, Yamamura Y, Kumar A. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female. AIDS Res Hum Retroviruses 2004, 20:684-686. 10.1089/0889222041217509, 15242547.
32. Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 2004, 78:10133-10148. 10.1128/JVI.78.18.10133-10148.2004, 515019, 15331746.
33. Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Gunthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005, 79:1772-1788. 10.1128/JVI.79.3.1772-1788.2005, 544082, 15650202.
34. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 2004, 279:51545-51553. 10.1074/jbc.M408573200, 1351161, 15452123.
35. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997, 71:2059-2071. 191294, 9032338.
36. van Marle G, Rourke SB, Zhang K, Silva C, Ethier J, Gill MJ, Power C. HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain. AIDS 2002, 16:1905-1914. 10.1097/00002030-200209270-00007, 12351950.
37. Voulgaropoulou F, Tan B, Soares M, Hahn B, Ratner L. Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia. J Virol 1999, 73:3497-3504. 104119, 10074209.
38. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999, 73:10489-10502. 113104, 10559367.
39. Song B, Cayabyab M, Phan N, Wang L, Axthelm MK, Letvin NL, Sodroski JG. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease. Virology 2004, 322:168-181. 10.1016/j.virol.2004.02.001, 15063126.
40. Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol 2005, 79:10830-10834. 10.1128/JVI.79.16.10830-10834.2005, 1182623, 16051875.
41. Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. Aids 2007, 21:1263-1272. 10.1097/QAD.0b013e3281864667, 17545702.
42. Anton PA, Elliott J, Poles MA, McGowan IM, Matud J, Hultin LE, Grovit-Ferbas K, Mackay CR, Chen ISY, Giorgi JV. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. Aids 2000, 14:1761-1765. 10.1097/00002030-200008180-00011, 10985313.
43. Olsson J, Poles M, Spetz AL, Elliott J, Hultin L, Giorgi J, Andersson J, Anton P. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 2000, 182:1625-1635. 10.1086/317625, 11069233.
44. Collins KR, Quinones-Mateu ME, Wu M, Luzze H, Johnson JL, Hirsch C, Toossi Z, Arts EJ. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol 2002, 76:1697-1706. 10.1128/JVI.76.4.1697-1706.2002, 135892, 11799165.
45. Potter SJ, Dwyer DE, Saksena NK. Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8+ T cells during HAART. Virology 2003, 305:339-352. 10.1006/viro.2002.1703, 12573579.
46. Potter SJ, Lemey P, Achaz G, Chew CB, Vandamme AM, Dwyer DE, Saksena NK. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J Leukoc Biol 2004, 76:562-570. 10.1189/jlb.0404234, 15218056.
47. Hasegawa T, Juni K, Saneyoshi M, Kawaguchi T. Intestinal absorption and first-pass elimination of 2', 3'-dideoxynucleosides following oral administration in rats. Biol Pharm Bull 1996, 19:599-603.
48. Busidan Y, Shi X, Dow-Edwards DL. AZT distribution in the fetal and postnatal rat central nervous system. J Pharm Sci 2001, 90:1964-1971. 10.1002/jps.1147, 11745755.
49. Hein WR. Organization of mucosal lymphoid tissue. Curr Top Microbiol Immunol 1999, 236:1-15.
50. Azzali G. Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue. Immunol Rev 2003, 195:178-189. 10.1034/j.1600-065X.2003.00072.x, 12969318.
51. Fujimura Y, Hosobe M, Kihara T. Ultrastructural study of M cells from colonic lymphoid nodules obtained by colonoscopic biopsy. Dig Dis Sci 1992, 37:1089-1098. 10.1007/BF01300292, 1618058.
52. O'Leary AD, Sweeney EC. Lymphoglandular complexes of the colon: structure and distribution. Histopathology 1986, 10:267-283. 10.1111/j.1365-2559.1986.tb02481.x, 3486153.
53. Frost SD, Dumaurier MJ, Wain-Hobson S, Brown AJ. Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci USA 2001, 98:6975-6980. 10.1073/pnas.131056998, 34518, 11381143.
54. Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson C, Borellini F, Lazar R, Hege KM. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. Aids 2003, 17:53-63. 10.1097/00002030-200301030-00008, 12478069.
55. Poles MA, Boscardin WJ, Elliott J, Taing P, Fuerst MM, McGowan I, Brown S, Anton PA. Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 2006, 43:65-68. 10.1097/01.qai.0000230524.71717.14, 16936559.
56. Zuckerman RA, Whittington WL, Celum CL, Collis TK, Lucchetti AJ, Sanchez JL, Hughes JP, Coombs RW. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J Infect Dis 2004, 190:156-161. 10.1086/421246, 15195255.
57. Hachiya A, Kodama EN, Sarafianos SG, Schuckmann MM, Sakagami Y, Matsuoka M, Takiguchi M, Gatanaga H, Oka S. Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol 2008, 82:3261-3270. 10.1128/JVI.01154-07, 2268505, 18216099.
58. Yap SH, Sheen CW, Fahey J, Zanin M, Tyssen D, Lima VD, Wynhoven B, Kuiper M, Sluis-Cremer N, Harrigan PR, Tachedjian G. N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance. PLoS Med 2007, 4:e335. 10.1371/journal.pmed.0040335, 2100143,2100143, 18052601.
59. Nikolenko GN, Delviks-Frankenberry KA, Palmer S, Maldarelli F, Fivash MJ, Coffin JM, Pathak VK. Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc Natl Acad Sci USA 2007, 104:317-322. 10.1073/pnas.0609642104, 1765458, 17179211.
60. Centlivre M, Sala M, Wain-Hobson S, Berkhout B. In HIV-1 pathogenesis the die is cast during primary infection. Aids 2007, 21:1-11. 10.1097/QAD.0b013e3280117f7f, 17148962.
61. Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF. Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single-Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1. J Infect Dis 2009, 199:1301-1309. 10.1086/597759, 2703715, 19338474.
62. Poles MA, Elliott J, Vingerhoets J, Michiels L, Scholliers A, Bloor S, Larder B, Hertogs K, Anton PA. Despite high concordance, distinct mutational and phenotypic drug resistance profiles in human immunodeficiency virus type 1 RNA are observed in gastrointestinal mucosal biopsy specimens and peripheral blood mononuclear cells compared with plasma. J Infect Dis 2001, 183:143-148. 10.1086/317640, 11087199.
63. Ostrowski MA, Chun TW, Justement SJ, Motola I, Spinelli MA, Adelsberger J, Ehler LA, Mizell SB, Hallahan CW, Fauci AS. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999, 73:6430-6435. 112723, 10400736.
64. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, Fauci AS. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998, 161:3195-3201.
65. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997, 94:1925-1930. 10.1073/pnas.94.5.1925, 20019, 9050881.
66. Venturi G, Romano L, Carli T, Corsi P, Pippi L, Valensin PE, Zazzi M. Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. Antivir Ther 2002, 7:245-250.
67. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599. 10.1093/molbev/msm092, 17488738.